Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × 68Ga-FAPI × Clear all

Phase

Phase EARLY_PHASE1 5 Phase NA 3 Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cisplatin 875 Cyclophosphamide 824 Carboplatin 817 Radiotherapy 764 Bevacizumab 719 Gemcitabine 691 pembrolizumab 648 Docetaxel 647 Paclitaxel 630 Oxaliplatin 597 Capecitabine 558 Fluorouracil 496 Rituximab 485 Nivolumab 431 Dexamethasone 424 Etoposide 398 Doxorubicin 388 Irinotecan 383 Drug Therapy 332 Leucovorin 330 Cytarabine 299 Cetuximab 288 Lenalidomide 283 Trastuzumab 280 Pemetrexed 275 durvalumab 254 Filgrastim 246 Temozolomide 232 Prednisone 230 Magnetic Resonance Spectroscopy 229

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04023240 2024-08-12

68-Ga-FAPI PET Imaging in Malignancy

Stanford University

Phase 2 Withdrawn

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡